p53 mutations and hepatitis B virus: cofactors in hepatocellular carcinoma

NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx.

Oncogene·2009

Stimulation of cellular proliferation by hepatitis B virus X protein.

Disease markers·2002

DDB2 induces nuclear accumulation of the hepatitis B virus X protein independently of binding to DDB1.

Journal of virology·2001

Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue.

The Journal of biological chemistry·2001

Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Journal of virology·2001

Dissociation of DDB1-binding and transactivation properties of the hepatitis B virus X protein.

Virus research·2000

Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

Hepatology (Baltimore, Md.)·2026

Drug-Induced Liver Injury (DILI) in clinical trials: Views and practical updates from DILI specialists at FDA.

Hepatology (Baltimore, Md.)·2026

Genetic regulation of CPEB3-mediated alternative polyadenylation associated with survival of patients with hepatocellular carcinoma.

Hepatology (Baltimore, Md.)·2026

Beyond cirrhosis: Major adverse liver outcomes across homozygous and heterozygous Alpha-1 antitrypsin deficiency associated liver disease.

Hepatology (Baltimore, Md.)·2026

Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

Hepatology (Baltimore, Md.)·2026

A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

Hepatology (Baltimore, Md.)·2026

Epstein-Barr virus based biomarkers and targeted therapies in nasopharyngeal carcinoma: a narrative review.

The Lancet regional health. Western Pacific·2026

Clinical and prognostic value of dynapenia in patients with head and neck cancer: a multicenter cohort study. VALOR group.

Frontiers in nutrition·2026

Intravascular Imaging to Predict the Coronary No-Reflow and Slow-Flow Phenomena: Advances and Perspectives.

Reviews in cardiovascular medicine·2026

Advances in galactose-based small-molecule hepatocyte-targeting probes for detecting biomarkers in hepatocellular carcinoma.

Frontiers in chemistry·2026

Risk factors and development of a nomogram prediction model for urinary dysfunction after laparoscopic radical surgery for rectal cancer.

Frontiers in surgery·2026

The Acidic Exosomal miR-1246/WASF3 Axis Regulates Hepatic Stellate Cell Activation and Stiff ECM Remodeling to Promote Pancreatic Ductal Adenocarcinoma Liver Metastasis.

International journal of biological sciences·2026

Related Experiment Videos

p53 mutations and hepatitis B virus: cofactors in hepatocellular carcinoma

Related Concept Videos

NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx.

Stimulation of cellular proliferation by hepatitis B virus X protein.

DDB2 induces nuclear accumulation of the hepatitis B virus X protein independently of binding to DDB1.

Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue.

Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Dissociation of DDB1-binding and transactivation properties of the hepatitis B virus X protein.

Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

Drug-Induced Liver Injury (DILI) in clinical trials: Views and practical updates from DILI specialists at FDA.

Genetic regulation of CPEB3-mediated alternative polyadenylation associated with survival of patients with hepatocellular carcinoma.

Beyond cirrhosis: Major adverse liver outcomes across homozygous and heterozygous Alpha-1 antitrypsin deficiency associated liver disease.

Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

Epstein-Barr virus based biomarkers and targeted therapies in nasopharyngeal carcinoma: a narrative review.

Clinical and prognostic value of dynapenia in patients with head and neck cancer: a multicenter cohort study. VALOR group.

Intravascular Imaging to Predict the Coronary No-Reflow and Slow-Flow Phenomena: Advances and Perspectives.

Advances in galactose-based small-molecule hepatocyte-targeting probes for detecting biomarkers in hepatocellular carcinoma.

Risk factors and development of a nomogram prediction model for urinary dysfunction after laparoscopic radical surgery for rectal cancer.

The Acidic Exosomal miR-1246/WASF3 Axis Regulates Hepatic Stellate Cell Activation and Stiff ECM Remodeling to Promote Pancreatic Ductal Adenocarcinoma Liver Metastasis.

Related Experiment Videos

p53 mutations and hepatitis B virus: cofactors in hepatocellular carcinoma

Related Concept Videos

Related Articles